We are global leaders
in wastewater intelligence

Biobot's work is trusted by agencies like the CDC and the NIH, as well as top vaccine manufacturers and hospital systems.

Biobot is the pioneer and global leader in wastewater epidemiology, transforming sewage into a real-time public health observatory. Founded out of a research project at MIT, Biobot provided the first detection of SARS-CoV-2 in wastewater in the U.S. in early 2020. Its pioneering work has expanded to monitor dozens of pathogens and high-risk substances across hundreds of communities, fueled by top venture investors and validated by SBIR Phase I, II, and III awards from the NIH.

Y Combinator-backed Biobot has been named a TIME100 Most Influential Company and Best Invention. In 2021 Fast Company named Biobot the third Most Influential Biotech Company, behind Covid-19 vaccine manufacturers Pfizer and Moderna. In 2026, Biobot’s cofounders were named to Inc. Magazine’s list of Top Female Founders in AI & Data.

Company / Board of directors

Board of Directors

Biobot’s Board of Directors brings together leaders in science, technology, and venture building.

backed by

Company / Board of Advisors

Board of Advisors

Biobot’s Board of Advisors brings together experts in public health, epidemiology, medical countermeasures, and biosecurity.

Protecting Privacy. Protecting Communities.

Biobot exists to protect communities, and our data is designed to do the same.

Our wastewater intelligence reveals which pathogens and substances are circulating at the community level, never who is carrying them. No individual, household, or address is ever identifiable.

That distinction matters. Community trust is the foundation of public health, and Biobot Analytics treats privacy as central to our mission, not an afterthought.

It is this privacy-first approach to wastewater intelligence that sets Biobot apart.